Regional drug delivery with radiation for the treatment of Ewing’s sarcoma: In vitro development of a taxol release system
- 2 April 2001
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 71 (2) , 193-202
- https://doi.org/10.1016/s0168-3659(01)00217-6
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Chemical changes during in vivo degradation of poly(anhydride-imide) matricesBiomaterials, 1998
- Preliminaryin vivo report on the osteocompatibility of poly(anhydride-co-imides) evaluated in a tibial modelJournal of Biomedical Materials Research, 1998
- Paclitaxel as a radiosensitiser: A proposed schedule of administration based on in vitro data and pharmacokinetic calculationsEuropean Journal Of Cancer, 1997
- In vitro degradation characteristics of poly(anhydride-imides) containing trimellitylimidoglycineJournal of Applied Polymer Science, 1997
- Preparation and Characterization of Poly(lactic-co-glycolic acid) Microspheres for Targeted Delivery of a Novel Anticancer Agent, Taxol.CHEMICAL & PHARMACEUTICAL BULLETIN, 1996
- Cytotoxicity testing of poly(anhydride‐co‐imides) for orthopedic applicationsJournal of Biomedical Materials Research, 1995
- Synthesis and Characterization of Degradable Poly(anhydride-co-imides)Macromolecules, 1995
- Taxol and taxotere—Current status and future prospectsEuropean Journal Of Cancer, 1993
- Investigation of taxol as a potential radiation sensitizerCancer, 1993
- Bone Sarcomas Linked to Radiotherapy and Chemotherapy in ChildrenNew England Journal of Medicine, 1987